TNFSF10 and hepatocellular carcinoma: The aim of these studies has been the identification of novel drugs that may selectively increase TRAIL sensitivity and therefore overcome the resistance of transformed hepatocytes towards TRAIL induced cytotoxicity (an extensive list of the compounds tested in combination with TRAIL in HCC cellular models has been provided in Table 2).